Dynasil Corporation of America (DYSL)

[jockinmikeg]

Lack of investor awareness, past performance including the drag of XCede, may be contributing factors. Also some have stated that management doesn't seem to be able to sell the story to Wall Street.

On that note, I think investor sentiment is turning around some. We got a partner for XCede to start the pre-clinicals, so positive progress will add value to biomedical and imo share price. Optics is growing. and current administration looks to be interested in increasing defense spending, which is good for RMD. Also, one of Sulick's CC responses seemed to allude that the major holders may be open to selling parts of the company since they own almost half of DYSL and are getting old. He said the board would meet in May, so who knows we may see a buyout or partial asset sale down the road.